ID   S22A7_HUMAN             Reviewed;         548 AA.
AC   Q9Y694; B2CZX6; Q5T046; Q5T048; Q5T050; Q9H2W5;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Solute carrier family 22 member 7;
DE   AltName: Full=Novel liver transporter;
DE   AltName: Full=Organic anion transporter 2;
DE            Short=hOAT2;
GN   Name=SLC22A7; Synonyms=NLT, OAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Kim R.B., Leake B.L., Cvetkovic M.;
RT   "Molecular cloning of a human liver-specific transporter, NLT.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Kidney;
RA   Reid G., Bahn A., Ebbinghaus C., Wolff N.A., Burckhardt G.;
RT   "Identification of a human organic anion transporter 2 homolog.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kobayashi Y., Ohshiro N., Sekine T., Endoh H., Yamamoto T.;
RT   "Cloning, characterization and localization of human organic anion
RT   transporter 2.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-303; TRP-327 AND
RP   VAL-507.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11327718; DOI=10.1006/bbrc.2001.4774;
RA   Sun W., Wu R.R., van Poelje P.D., Erion M.D.;
RT   "Isolation of a family of organic anion transporters from human liver
RT   and kidney.";
RL   Biochem. Biophys. Res. Commun. 283:417-422(2001).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12023506; DOI=10.1124/jpet.301.3.797;
RA   Enomoto A., Takeda M., Shimoda M., Narikawa S., Kobayashi Y.,
RA   Kobayashi Y., Yamamoto T., Sekine T., Cha S.H., Niwa T., Endou H.;
RT   "Interaction of human organic anion transporters 2 and 4 with organic
RT   anion transport inhibitors.";
RL   J. Pharmacol. Exp. Ther. 301:797-802(2002).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11907186; DOI=10.1124/jpet.301.1.293;
RA   Kimura H., Takeda M., Narikawa S., Enomoto A., Ichida K., Endou H.;
RT   "Human organic anion transporters and human organic cation
RT   transporters mediate renal transport of prostaglandins.";
RL   J. Pharmacol. Exp. Ther. 301:293-298(2002).
RN   [12]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11855680; DOI=10.1254/jjp.88.69;
RA   Babu E., Takeda M., Narikawa S., Kobayashi Y., Yamamoto T., Cha S.H.,
RA   Sekine T., Sakthisekaran D., Endou H.;
RT   "Human organic anion transporters mediate the transport of
RT   tetracycline.";
RL   Jpn. J. Pharmacol. 88:69-76(2002).
RN   [13]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15901346; DOI=10.1211/0022357055966;
RA   Kobayashi Y., Ohshiro N., Sakai R., Ohbayashi M., Kohyama N.,
RA   Yamamoto T.;
RT   "Transport mechanism and substrate specificity of human organic anion
RT   transporter 2 (hOat2 [SLC22A7]).";
RL   J. Pharm. Pharmacol. 57:573-578(2005).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-91.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
CC   -!- FUNCTION: Mediates sodium-independent multispecific organic anion
CC       transport. Transport of prostaglandin E2, prostaglandin F2,
CC       tetracycline, bumetanide, estrone sulfate, glutarate,
CC       dehydroepiandrosterone sulfate, allopurinol, 5-fluorouracil,
CC       paclitaxel, L-ascorbic acid, salicylate, ethotrexate, and alpha-
CC       ketoglutarate. {ECO:0000269|PubMed:11327718,
CC       ECO:0000269|PubMed:11855680, ECO:0000269|PubMed:11907186,
CC       ECO:0000269|PubMed:12023506, ECO:0000269|PubMed:15901346}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=713 nM for prostaglandin E2 {ECO:0000269|PubMed:11855680,
CC         ECO:0000269|PubMed:11907186};
CC         KM=440 uM for tetracycline {ECO:0000269|PubMed:11855680,
CC         ECO:0000269|PubMed:11907186};
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:11907186, ECO:0000269|PubMed:12023506}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:11907186,
CC       ECO:0000269|PubMed:12023506}. Note=Apical side of the renal
CC       tubule.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Y694-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y694-2; Sequence=VSP_030992;
CC       Name=3;
CC         IsoId=Q9Y694-3; Sequence=VSP_030992, VSP_030994;
CC       Name=4;
CC         IsoId=Q9Y694-4; Sequence=VSP_030991, VSP_030993;
CC   -!- TISSUE SPECIFICITY: Expressed in liver and kidney.
CC       {ECO:0000269|PubMed:11327718, ECO:0000269|PubMed:11907186,
CC       ECO:0000269|PubMed:15901346}.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1)
CC       superfamily. Organic cation transporter (TC 2.A.1.19) family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/slc22a7/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF097518; AAD37091.1; -; mRNA.
DR   EMBL; AF210455; AAG43523.1; -; mRNA.
DR   EMBL; AY050498; AAL12496.1; -; mRNA.
DR   EMBL; AK290796; BAF83485.1; -; mRNA.
DR   EMBL; AK290806; BAF83495.1; -; mRNA.
DR   EMBL; EU562669; ACB21045.1; -; Genomic_DNA.
DR   EMBL; AL583834; CAI14466.1; -; Genomic_DNA.
DR   EMBL; AL583834; CAI14462.1; -; Genomic_DNA.
DR   EMBL; AL583834; CAI14463.1; -; Genomic_DNA.
DR   EMBL; AL583834; CAI14464.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04172.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04175.1; -; Genomic_DNA.
DR   EMBL; BC033805; AAH33805.1; -; mRNA.
DR   CCDS; CCDS4892.1; -. [Q9Y694-2]
DR   CCDS; CCDS4893.2; -. [Q9Y694-1]
DR   RefSeq; NP_006663.2; NM_006672.3. [Q9Y694-2]
DR   RefSeq; NP_696961.2; NM_153320.2. [Q9Y694-1]
DR   UniGene; Hs.485438; -.
DR   ProteinModelPortal; Q9Y694; -.
DR   IntAct; Q9Y694; 2.
DR   STRING; 9606.ENSP00000361666; -.
DR   BindingDB; Q9Y694; -.
DR   ChEMBL; CHEMBL1955711; -.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00437; Allopurinol.
DR   DrugBank; DB00345; Aminohippuric acid.
DR   DrugBank; DB00887; Bumetanide.
DR   DrugBank; DB00456; Cefalotin.
DR   DrugBank; DB01326; Cefamandole.
DR   DrugBank; DB01329; Cefoperazone.
DR   DrugBank; DB00493; Cefotaxime.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB01211; Clarithromycin.
DR   DrugBank; DB02527; Cyclic Adenosine Monophosphate.
DR   DrugBank; DB01160; Dinoprost Tromethamine.
DR   DrugBank; DB00917; Dinoprostone.
DR   DrugBank; DB01248; Docetaxel.
DR   DrugBank; DB00584; Enalapril.
DR   DrugBank; DB00544; Fluorouracil.
DR   DrugBank; DB01004; Ganciclovir.
DR   DrugBank; DB03553; Glutaric Acid.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB01009; Ketoprofen.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB01017; Minocycline.
DR   DrugBank; DB01303; Oxtriphylline.
DR   DrugBank; DB00595; Oxytetracycline.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB00936; Salicylic acid.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB00759; Tetracycline.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB00313; Valproic Acid.
DR   DrugBank; DB00943; Zalcitabine.
DR   DrugBank; DB00495; Zidovudine.
DR   TCDB; 2.A.1.19.25; the major facilitator superfamily (mfs).
DR   iPTMnet; Q9Y694; -.
DR   PhosphoSitePlus; Q9Y694; -.
DR   BioMuta; SLC22A7; -.
DR   DMDM; 74753520; -.
DR   PaxDb; Q9Y694; -.
DR   PeptideAtlas; Q9Y694; -.
DR   PRIDE; Q9Y694; -.
DR   DNASU; 10864; -.
DR   Ensembl; ENST00000372574; ENSP00000361655; ENSG00000137204. [Q9Y694-3]
DR   Ensembl; ENST00000372585; ENSP00000361666; ENSG00000137204. [Q9Y694-1]
DR   Ensembl; ENST00000372589; ENSP00000361670; ENSG00000137204. [Q9Y694-2]
DR   GeneID; 10864; -.
DR   KEGG; hsa:10864; -.
DR   UCSC; uc003ous.4; human. [Q9Y694-1]
DR   CTD; 10864; -.
DR   DisGeNET; 10864; -.
DR   GeneCards; SLC22A7; -.
DR   HGNC; HGNC:10971; SLC22A7.
DR   HPA; HPA030220; -.
DR   MIM; 604995; gene.
DR   neXtProt; NX_Q9Y694; -.
DR   OpenTargets; ENSG00000137204; -.
DR   PharmGKB; PA35848; -.
DR   eggNOG; KOG0255; Eukaryota.
DR   eggNOG; COG0477; LUCA.
DR   GeneTree; ENSGT00760000118852; -.
DR   HOGENOM; HOG000234569; -.
DR   HOVERGEN; HBG108433; -.
DR   InParanoid; Q9Y694; -.
DR   KO; K08204; -.
DR   OMA; HCARLNG; -.
DR   OrthoDB; EOG091G07GO; -.
DR   PhylomeDB; Q9Y694; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-HSA-561048; Organic anion transport.
DR   GeneWiki; SLC22A7; -.
DR   GenomeRNAi; 10864; -.
DR   PRO; PR:Q9Y694; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000137204; -.
DR   CleanEx; HS_SLC22A7; -.
DR   ExpressionAtlas; Q9Y694; baseline and differential.
DR   Genevisible; Q9Y694; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015301; F:anion:anion antiporter activity; TAS:Reactome.
DR   GO; GO:0005452; F:inorganic anion exchanger activity; IBA:GO_Central.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015711; P:organic anion transport; TAS:ProtInc.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; IBA:GO_Central.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR004749; Orgcat_transp/SVOP.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   TIGRFAMs; TIGR00898; 2A0119; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion transport; Membrane; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    548       Solute carrier family 22 member 7.
FT                                /FTId=PRO_0000317481.
FT   TRANSMEM     21     41       Helical. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical. {ECO:0000255}.
FT   TRANSMEM    180    200       Helical. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical. {ECO:0000255}.
FT   TRANSMEM    234    254       Helical. {ECO:0000255}.
FT   TRANSMEM    259    279       Helical. {ECO:0000255}.
FT   TRANSMEM    346    366       Helical. {ECO:0000255}.
FT   TRANSMEM    376    397       Helical. {ECO:0000255}.
FT   TRANSMEM    404    423       Helical. {ECO:0000255}.
FT   TRANSMEM    432    452       Helical. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical. {ECO:0000255}.
FT   TRANSMEM    493    513       Helical. {ECO:0000255}.
FT   CARBOHYD     91     91       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ       1    307       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_030991.
FT   VAR_SEQ     132    133       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_030992.
FT   VAR_SEQ     308    317       PVCEDSFSQE -> MLQPHLLPYQ (in isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_030993.
FT   VAR_SEQ     531    548       SAPTSLQEEEMPMKQVQN -> RCVHRTVSVYV (in
FT                                isoform 3). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_030994.
FT   VARIANT     303    303       R -> K (in dbSNP:rs70953684).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_047875.
FT   VARIANT     327    327       R -> W (in dbSNP:rs36040909).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_047876.
FT   VARIANT     507    507       G -> V (in dbSNP:rs70953693).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_047877.
FT   CONFLICT    304    304       L -> P (in Ref. 2; AAG43523).
FT                                {ECO:0000305}.
FT   CONFLICT    413    413       T -> A (in Ref. 2; AAG43523).
FT                                {ECO:0000305}.
SQ   SEQUENCE   548 AA;  60026 MW;  5BA4C3FCC3C57533 CRC64;
     MGFEELLEQV GGFGPFQLRN VALLALPRVL LPLHFLLPIF LAAVPAHRCA LPGAPANFSH
     QDVWLEAHLP REPDGTLSSC LRFAYPQALP NTTLGEERQS RGELEDEPAT VPCSQGWEYD
     HSEFSSTIAT ESQWDLVCEQ KGLNRAASTF FFAGVLVGAV AFGYLSDRFG RRRLLLVAYV
     STLVLGLASA ASVSYVMFAI TRTLTGSALA GFTIIVMPLE LEWLDVEHRT VAGVLSSTFW
     TGGVMLLALV GYLIRDWRWL LLAVTLPCAP GILSLWWVPE SARWLLTQGH VKEAHRYLLH
     CARLNGRPVC EDSFSQEAVS KVAAGERVVR RPSYLDLFRT PRLRHISLCC VVVWFGVNFS
     YYGLSLDVSG LGLNVYQTQL LFGAVELPSK LLVYLSVRYA GRRLTQAGTL LGTALAFGTR
     LLVSSDMKSW STVLAVMGKA FSEAAFTTAY LFTSELYPTV LRQTGMGLTA LVGRLGGSLA
     PLAALLDGVW LSLPKLTYGG IALLAAGTAL LLPETRQAQL PETIQDVERK SAPTSLQEEE
     MPMKQVQN
//
